Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors.

Can, Bilge

Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors. [electronic resource] - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica Sep 2012 - 689-98 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1600-0463

10.1111/j.1600-0463.2012.02887.x doi


Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--metabolism
Disease-Free Survival
Female
Gastrointestinal Neoplasms--metabolism
Gastrointestinal Stromal Tumors--metabolism
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Retrospective Studies
Thymosin--metabolism
Vascular Endothelial Growth Factor A--metabolism